Microbix Biosystems Stock Analysis
| MBX Stock | CAD 0.31 0.01 3.13% |
Microbix Biosystems is overvalued with Real Value of 0.27 and Hype Value of 0.31. The main objective of Microbix Biosystems stock analysis is to determine its intrinsic value, which is an estimate of what Microbix Biosystems is worth, separate from its market price. There are two main types of Microbix Biosystems' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Microbix Biosystems' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Microbix Biosystems' stock to identify patterns and trends that may indicate its future price movements.
The Microbix Biosystems stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Microbix Biosystems is usually not traded on Canada Day, Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Microbix Stock trading window is adjusted to America/Toronto timezone.
Microbix |
Microbix Stock Analysis Notes
About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.49. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Microbix Biosystems last dividend was issued on the 2nd of September 1999. Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada. To find out more about Microbix Biosystems contact Cameron Groome at 905 361 8910 or learn more at https://www.microbix.com.Microbix Biosystems Quarterly Total Revenue |
|
Microbix Biosystems Investment Alerts
| Microbix Biosystems generated a negative expected return over the last 90 days | |
| Microbix Biosystems has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 16.51 M. Net Loss for the year was (39.48 K) with profit before overhead, payroll, taxes, and interest of 11.12 M. | |
| Microbix Biosystems has accumulated about 402.12 K in cash with (1.09 M) of positive cash flow from operations. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Stocks In Play Microbix Biosystems Inc. - Barchart |
Microbix Largest EPS Surprises
Earnings surprises can significantly impact Microbix Biosystems' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-08-11 | 2022-06-30 | 0.01 | 0.0045 | -0.0055 | 55 | ||
2023-05-11 | 2023-03-31 | 0.01 | 2.0E-4 | -0.0098 | 98 | ||
2023-08-10 | 2023-06-30 | 0.01 | -0.01 | -0.02 | 200 |
Microbix Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 42.38 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Microbix Biosystems's market, we take the total number of its shares issued and multiply it by Microbix Biosystems's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Microbix Profitablity
Microbix Biosystems' profitability indicators refer to fundamental financial ratios that showcase Microbix Biosystems' ability to generate income relative to its revenue or operating costs. If, let's say, Microbix Biosystems is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Microbix Biosystems' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Microbix Biosystems' profitability requires more research than a typical breakdown of Microbix Biosystems' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03. | Last Reported | Projected for Next Year | ||
| Return On Capital Employed | (0.08) | (0.08) |
Management Efficiency
Microbix Biosystems has return on total asset (ROA) of 0.0382 % which means that it generated a profit of $0.0382 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2004 %, meaning that it generated $0.2004 on every $100 dollars invested by stockholders. Microbix Biosystems' management efficiency ratios could be used to measure how well Microbix Biosystems manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to drop to -0.0012. In addition to that, Return On Capital Employed is likely to drop to -0.08. At this time, Microbix Biosystems' Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.16 | 0.09 | |
| Tangible Book Value Per Share | 0.13 | 0.14 | |
| Enterprise Value Over EBITDA | 22.21 | 12.84 | |
| Price Book Value Ratio | 2.00 | 1.90 | |
| Enterprise Value Multiple | 22.21 | 12.84 | |
| Price Fair Value | 2.00 | 1.90 | |
| Enterprise Value | 34 M | 24.1 M |
Leadership effectiveness at Microbix Biosystems is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin 0.0327 | Profit Margin 0.2173 | Beta 0.343 | Return On Assets 0.0382 | Return On Equity 0.2004 |
Technical Drivers
As of the 30th of November, Microbix Biosystems secures the Risk Adjusted Performance of (0.11), standard deviation of 1.94, and Mean Deviation of 1.35. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Microbix Biosystems, as well as the relationship between them.Microbix Biosystems Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Microbix Biosystems middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Microbix Biosystems. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Microbix Biosystems Outstanding Bonds
Microbix Biosystems issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Microbix Biosystems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Microbix bonds can be classified according to their maturity, which is the date when Microbix Biosystems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Microbix Biosystems Predictive Daily Indicators
Microbix Biosystems intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Microbix Biosystems stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Microbix Biosystems Forecast Models
Microbix Biosystems' time-series forecasting models are one of many Microbix Biosystems' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Microbix Biosystems' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Microbix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Microbix Biosystems prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Microbix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Microbix Biosystems. By using and applying Microbix Stock analysis, traders can create a robust methodology for identifying Microbix entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Operating Profit Margin | (0.15) | (0.16) | |
| Gross Profit Margin | 0.52 | 0.63 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Microbix Biosystems to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pattern Recognition Now
Pattern RecognitionUse different Pattern Recognition models to time the market across multiple global exchanges |
| All Next | Launch Module |
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.